Search

everythinglearnresearchcommunity

for

Search:↓

Patients with long COVID after Omicron had fewer hospitalizations and milder symptoms but more fatigue, insomnia, and cough compared to those with Delta.

Telemedicine is effective for diagnosing hair loss, especially in people with darker skin, during the pandemic.

Long COVID affects many body systems and needs careful management.

Over half of the participants in a Saudi Arabian survey experienced hair loss after COVID-19, affecting women and younger people more, with a small percentage feeling a severe impact on their lives.

Rehabilitation therapy helped a severe COVID-19 patient regain muscle mass and return to normal life.

Organoid technology is advancing and entering commercial use, with applications in disease modeling, drug development, and personalized medicine.

COVID-19 can cause long-term skin problems and has changed how skin doctors work.

There is no link between hair loss and prostate enlargement.

New therapies are being developed that target integrin pathways to treat various diseases.

Teledermatology became a valuable and convenient tool for skin care during the COVID-19 pandemic.

Self-amplifying RNA could be a better option for protein replacement therapy with lower doses and lasting effects, but delivering it into cells is still challenging.

Older, obese people with many COVID-19 symptoms are more likely to suffer from severe long-term COVID-19 effects.

Teledermatology was popular among young adults and women, and high-resolution photos improved service during the pandemic.

Cordyceps militaris is a promising, cost-effective medicinal fungus with health benefits and efficient production methods.

Women with type D personality and PCOS experience more stress and use less effective coping strategies.

Hormone replacement therapy may lower the risk of severe COVID-19 outcomes in non-immunosuppressed people and male organ transplant recipients.

Cannabis may help with skin and hair health but could also increase heart and stroke risks.

Afatinib, neratinib, and zanubrutinib could be effective against KRASG12C-mutant tumors.

Androgenetic alopecia is linked to heart disease, metabolic issues, and mental health problems.

Scalp inflammation can cause multiple hairs to grow from one follicle.

Some COVID-19 patients lose hair, with the most common type linked to male hormones and possibly increasing the risk of severe illness.

Trichoscopy is a reliable method for diagnosing hair-pulling disorder.

Skin organoids from stem cells could better mimic real skin but face challenges.

Magnetic nanovesicles from stem cells can improve hair growth by staying in the skin longer.

Shi-Bi-Man, a Traditional Chinese Medicine, helps grow hair by boosting lactic acid metabolism and activating hair follicle stem cells.

Sunlight exposure damages hair follicles, but certain stem cell-derived particles can reduce this damage and help with hair regeneration.

Lysophospholipids like LPA and S1P are important for hair growth, immune responses, and vascular development, and could be targeted for treating diseases.

Visualizing data helps guide future androgenetic alopecia research and policies.

Minoxidil patches and cold plasma may help treat hair loss.